H19 and neoplasm: Furthermore, the clonogenicity, migration and sphere-forming ability remained substantially lower in the cells isolated from the shH19 tumor xenografts of the second transplantation, with 66.8% knockdown efficiency of H19 (Figure 3c) in comparison with the cells from the NTC tumor xenografts (Figures 3d–f).